Chinese big data oncology firm LinkDoc raises $151mn
Chinese company LinkDoc Technology Ltd has just completed its series D funding round, raising $151mn from investors, China Money Network has reported. The investment was led by the sovereign wealth fund, China Investment Corporation (CIC).
LinkDoc is an oncology big data company which collects and standardises healthcare data from hospitals for over 3,000 diseases. The company was founded in 2014 and utilises AI and Big Data to provide customised information for the use of healthcare regulators, researchers, insurers and pharmaceutical companies.
See also:
Chinese healthcare app prepares for $1bn IPO
Alibaba Health partners with Chinese hospitals to develop AI in healthcare
Tencent partners with Aviva to sell online insurance
The business has partnerships with over 500 hospitals across 30 provinces and regional in China and describes itself as “the world’s leading provider of artificial intelligence and medical big data solutions”.
Working across medical institutions, the pharmaceutical industry, the insurance industry and individual patients outside of hospital, the company says it has collaborated with over 600 departments from over 300 top oncology centres in China.
Leading investor CIC is wholly state-owned and manages part of China’s foreign exchange reserves. It was established in 2007 and its most recently recorded AUM (assets under management) figure stands at $810bn.
Featured Articles
Nirvik Singh, Global COO and President International of Grey Group, cultivating culture and utilising AI to enhance rather than replace human creativity
On a mission to accelerate the adoption of sustainable energy solutions, US$30 billion Chinese tech firm Longi is not just selling solar – but using it
Armed with an ambitious billion-dollar strategy, Samsung is on track to achieve net zero carbon emissions company-wide by 2050 – but challenges persist